Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer

Marc E Lippman, M. E. Lippman, E. B. Thompson, R. Simon, A. Barlock, L. Green, K. K. Huff, H. M. Do, S. C. Aitken, R. Warren

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The influence of steroid hormone receptors on response rate to endocrine therapy in 85 patients with metastatic breast cancer was determined in a retrospective study. We have previously reported that estrogen receptor status has an overwhelming influence on predicting response to therapy when compared to other prognostic variables. In the present study, we expand our analysis to include the results of progesterone, androgen, and glucocorticoid receptors. Of 18 patients whose tumors contained progesterone receptor, 11 responded to endocrine therapy, compared to 8 of 26 patients with low or absent progesterone receptor. Progesterone receptor increased the predictive index of the estrogen receptor in a group of patients who had received no prior therapy, but it did not help in patients who had received prior endocrine therapy. None of four patients whose tumors were estrogen receptor negative but progesterone receptor positive responded to endocrine therapy. At the present time, there are trends suggesting a possible association between androgen and glucocorticoid receptor and response to endocrine therapy. These trends are apparent only with a cutoff value of 10 fmol/mg cytoplasmic protein, and the distributions of androgen and glucocorticoid receptor values for responders and nonresponders are not significantly different. Knowledge of androgen receptor status does not increase the predictive index in estrogen receptor-positive tumors or estrogen receptor-negative tumors. Glucocorticoid receptor positivity may increase the predictive index in estrogen receptor-positive tumors, but not in estrogen receptor-negative tumors.

Original languageEnglish
Pages (from-to)1973-1979
Number of pages7
JournalCancer Research
Volume39
Issue number6 I
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Androgen Receptors
Progesterone Receptors
Estrogen Receptors
Breast Neoplasms
Neoplasms
Therapeutics
Steroid Receptors
Retrospective Studies
Hormones
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lippman, M. E., Lippman, M. E., Thompson, E. B., Simon, R., Barlock, A., Green, L., ... Warren, R. (1979). Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Research, 39(6 I), 1973-1979.

Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. / Lippman, Marc E; Lippman, M. E.; Thompson, E. B.; Simon, R.; Barlock, A.; Green, L.; Huff, K. K.; Do, H. M.; Aitken, S. C.; Warren, R.

In: Cancer Research, Vol. 39, No. 6 I, 01.12.1979, p. 1973-1979.

Research output: Contribution to journalArticle

Lippman, ME, Lippman, ME, Thompson, EB, Simon, R, Barlock, A, Green, L, Huff, KK, Do, HM, Aitken, SC & Warren, R 1979, 'Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer', Cancer Research, vol. 39, no. 6 I, pp. 1973-1979.
Lippman, Marc E ; Lippman, M. E. ; Thompson, E. B. ; Simon, R. ; Barlock, A. ; Green, L. ; Huff, K. K. ; Do, H. M. ; Aitken, S. C. ; Warren, R. / Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. In: Cancer Research. 1979 ; Vol. 39, No. 6 I. pp. 1973-1979.
@article{1d661a60c2c74a2486942a7d12ec50c3,
title = "Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer",
abstract = "The influence of steroid hormone receptors on response rate to endocrine therapy in 85 patients with metastatic breast cancer was determined in a retrospective study. We have previously reported that estrogen receptor status has an overwhelming influence on predicting response to therapy when compared to other prognostic variables. In the present study, we expand our analysis to include the results of progesterone, androgen, and glucocorticoid receptors. Of 18 patients whose tumors contained progesterone receptor, 11 responded to endocrine therapy, compared to 8 of 26 patients with low or absent progesterone receptor. Progesterone receptor increased the predictive index of the estrogen receptor in a group of patients who had received no prior therapy, but it did not help in patients who had received prior endocrine therapy. None of four patients whose tumors were estrogen receptor negative but progesterone receptor positive responded to endocrine therapy. At the present time, there are trends suggesting a possible association between androgen and glucocorticoid receptor and response to endocrine therapy. These trends are apparent only with a cutoff value of 10 fmol/mg cytoplasmic protein, and the distributions of androgen and glucocorticoid receptor values for responders and nonresponders are not significantly different. Knowledge of androgen receptor status does not increase the predictive index in estrogen receptor-positive tumors or estrogen receptor-negative tumors. Glucocorticoid receptor positivity may increase the predictive index in estrogen receptor-positive tumors, but not in estrogen receptor-negative tumors.",
author = "Lippman, {Marc E} and Lippman, {M. E.} and Thompson, {E. B.} and R. Simon and A. Barlock and L. Green and Huff, {K. K.} and Do, {H. M.} and Aitken, {S. C.} and R. Warren",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "39",
pages = "1973--1979",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "6 I",

}

TY - JOUR

T1 - Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer

AU - Lippman, Marc E

AU - Lippman, M. E.

AU - Thompson, E. B.

AU - Simon, R.

AU - Barlock, A.

AU - Green, L.

AU - Huff, K. K.

AU - Do, H. M.

AU - Aitken, S. C.

AU - Warren, R.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - The influence of steroid hormone receptors on response rate to endocrine therapy in 85 patients with metastatic breast cancer was determined in a retrospective study. We have previously reported that estrogen receptor status has an overwhelming influence on predicting response to therapy when compared to other prognostic variables. In the present study, we expand our analysis to include the results of progesterone, androgen, and glucocorticoid receptors. Of 18 patients whose tumors contained progesterone receptor, 11 responded to endocrine therapy, compared to 8 of 26 patients with low or absent progesterone receptor. Progesterone receptor increased the predictive index of the estrogen receptor in a group of patients who had received no prior therapy, but it did not help in patients who had received prior endocrine therapy. None of four patients whose tumors were estrogen receptor negative but progesterone receptor positive responded to endocrine therapy. At the present time, there are trends suggesting a possible association between androgen and glucocorticoid receptor and response to endocrine therapy. These trends are apparent only with a cutoff value of 10 fmol/mg cytoplasmic protein, and the distributions of androgen and glucocorticoid receptor values for responders and nonresponders are not significantly different. Knowledge of androgen receptor status does not increase the predictive index in estrogen receptor-positive tumors or estrogen receptor-negative tumors. Glucocorticoid receptor positivity may increase the predictive index in estrogen receptor-positive tumors, but not in estrogen receptor-negative tumors.

AB - The influence of steroid hormone receptors on response rate to endocrine therapy in 85 patients with metastatic breast cancer was determined in a retrospective study. We have previously reported that estrogen receptor status has an overwhelming influence on predicting response to therapy when compared to other prognostic variables. In the present study, we expand our analysis to include the results of progesterone, androgen, and glucocorticoid receptors. Of 18 patients whose tumors contained progesterone receptor, 11 responded to endocrine therapy, compared to 8 of 26 patients with low or absent progesterone receptor. Progesterone receptor increased the predictive index of the estrogen receptor in a group of patients who had received no prior therapy, but it did not help in patients who had received prior endocrine therapy. None of four patients whose tumors were estrogen receptor negative but progesterone receptor positive responded to endocrine therapy. At the present time, there are trends suggesting a possible association between androgen and glucocorticoid receptor and response to endocrine therapy. These trends are apparent only with a cutoff value of 10 fmol/mg cytoplasmic protein, and the distributions of androgen and glucocorticoid receptor values for responders and nonresponders are not significantly different. Knowledge of androgen receptor status does not increase the predictive index in estrogen receptor-positive tumors or estrogen receptor-negative tumors. Glucocorticoid receptor positivity may increase the predictive index in estrogen receptor-positive tumors, but not in estrogen receptor-negative tumors.

UR - http://www.scopus.com/inward/record.url?scp=0018769728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018769728&partnerID=8YFLogxK

M3 - Article

C2 - 445396

AN - SCOPUS:0018769728

VL - 39

SP - 1973

EP - 1979

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 6 I

ER -